Attached files

file filename
10-Q - 10-Q - CytoDyn Inc.d859184d10q.htm
EX-32.2 - EX-32.2 - CytoDyn Inc.d859184dex322.htm
EX-31.2 - EX-31.2 - CytoDyn Inc.d859184dex312.htm
EX-31.1 - EX-31.1 - CytoDyn Inc.d859184dex311.htm
EX-10.9 - EX-10.9 - CytoDyn Inc.d859184dex109.htm
EX-3.1 - EX-3.1 - CytoDyn Inc.d859184dex31.htm

Exhibit 32.1

Certification of Chief Executive Officer

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the Quarterly Report of CytoDyn Inc. (the “Company”) on Form 10-Q for the fiscal quarter ended February 29, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-Q”), I, Nader Z. Pourhassan, President and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that based on my knowledge:

 

  (1)

The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

 

  (2)

The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 9, 2020   

/s/ Nader Z. Pourhassan

   Nader Z. Pourhassan
   President and Chief Executive Officer